In November xxxx, the North American Aniline market experienced a bullish trend, driven by steady consumption and constrained supply availability. The market faced supply constraints, which were exacerbated by disruptions in production and logistics, leading to a tightening of inventory levels.
In the first half of the month, the Aniline production rates were intermediate in the producing country, supported by moderate feedstock availability. At the same time, supply levels from China, a key Aniline exporting market, were slightly reduced due to ongoing disruptions in container shipping services in the East China Sea. Port congestion and vessel delays caused by Typhoon Kong-Rey, which struck Taiwan and moved northward, affected eastern China and Japan, further complicating supply chains.
The Aniline offtakes stayed consistent in the pharmaceutical industry. The Pharmaceutical sector showed signs of recovery, driven by multiple FDA approvals that helped companies like Gilead Sciences...
